Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study

Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC studyClinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study, Published online: 07 May 2019; doi:10.1038/s41416-019-0466-xClinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study

Source: British Journal of Cancer - May 6, 2019 Category: Cancer & Oncology Authors: David J. Pinato Francesco A. Mauri Paolo Spina Owen Cain Abdul Siddique Robert Goldin Stephane Victor Corinna Pizio Ayse U. Akarca Renzo L. Boldorini Luca Mazzucchelli James R. M. Black Shishir Shetty Teresa Marafioti Rohini Sharma Source Type: research